BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sockett P, Goebel SE, Varela NP, Guthrie A, Wilson J, Guilbault LA, Clark WF. Verotoxigenic Escherichia coli: costs of illness in Canada, including long-term health outcomes. J Food Prot 2014;77:216-26. [PMID: 24490915 DOI: 10.4315/0362-028X.JFP-13-177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Lisboa LF, Szelewicki J, Lin A, Latonas S, Li V, Zhi S, Parsons BD, Berenger B, Fathima S, Chui L. Epidemiology of Shiga Toxin-Producing Escherichia coli O157 in the Province of Alberta, Canada, 2009-2016. Toxins (Basel) 2019;11:E613. [PMID: 31652648 DOI: 10.3390/toxins11100613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ochieng’ BJ, Hobbs JE. Factors affecting cattle producers’ willingness to adopt an Escherichia coli O157:H7 vaccine: a probit analysis. International Food and Agribusiness Management Review 2017;20:347-63. [DOI: 10.22434/ifamr2016.0177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]